The combination of ınterleukin-10 -1082 and tumor necrosis factor α -308 or ınterleukin-6 -174 genes polymorphisms suggests an association with susceptibility to Hashimoto's thyroiditis. 2012

Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
Department of Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Çapa, Istanbul, Turkey.

BACKGROUND The etiopathogenesis of Hashimoto's thyroiditis (HT) has not been clearly elucidated although the role of chronical inflammation and endothelial dysfunction has been established. The imbalance between pro- and anti-inflammatory cytokines may play a role in the etiology. The aim of the present study was to investigate whether cytokine gene polymorphisms are associated with HT, and to evaluate the relationship between genotypes and clinical/laboratory manifestation of HT. METHODS Tumor necrosis factor α (TNFα) G-308A (rs 1800629), interleukin-6 (IL-6) G-174C (rs 1800795) and IL-10 G-1082A (rs 1800896) single nucleotide polymorphisms (SNPs) in DNA from peripheral blood leukocytes of 190 patients with HT and 231 healthy controls were investigated by real-time PCR combined with melting curve analysis using fluorescence-labeled hybridization probes. RESULTS There was no notable risk for HT afflicted by TNFα -308, IL-6 -174 and IL-10 -1082 polymorphisms alone. However, carriers of variant alleles of both IL-10 -1082 and TNFα -308 polymorphisms had four-fold times higher risk for HT in comparison with non-carriers. Additionally, concomitant presence of both mutant IL-10 -1082 A and IL-6 -174 C alleles raised three-fold the HT risk. CONCLUSIONS Our results suggest that the combined effects of TNFα -308, IL-6 -174 and IL-10 -1082 variant alleles may be more decisive to induce functional differences and modify the risk for HT.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
May 2010, European journal of obstetrics, gynecology, and reproductive biology,
Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
December 2009, Acta neurologica Scandinavica,
Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
May 2012, Human immunology,
Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
October 2012, Journal of dermatological science,
Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
January 2008, Allergy and asthma proceedings,
Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
January 2017, Mediators of inflammation,
Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
February 2013, Cytokine,
Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
January 2007, Pediatric cardiology,
Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
April 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Merve Baki, and Fevziye E Akman, and Pervin Vural, and Semra Doğru-Abbasoğlu, and Ayşenur Özderya, and Berrin Karadağ, and Müjdat Uysal
August 2013, Molecular biology reports,
Copied contents to your clipboard!